Authors
Latest:
AI’s Shot in the Arm of Science and the Concerns We Need to AddressStakeholders need to convene honest, actionable discussions about the challenges and the safeguards needed to address appropriate use of artificial intelligence in health care.
Latest:
Understand Tofersen, the First FDA-Approved Drug Targeted to Slow Disease Progression in SOD1-Mutated ALSPharmacists play a key role in optimizing drug therapy according to the most updated guidelines, educating patients or prescribers, and monitoring therapeutic outcomes.
Latest:
Mild to Moderate Adverse Events Possible in Pediatric Patients With Primary Immunodeficiency Receiving IVIGDespite being an effective treatment option, intravenous immunoglobulin (IVIG) can cause transient adverse events in pediatrics with primary immunodeficiency, including headache and fever.
Latest:
Getting in the Mindset to Become a Successful Preceptor: How to Precept ResponsiblyStudents should prepare to be preceptors early in their pharmacy school careers.
Latest:
From Abemaciclib to Trastuzumab Deruxtecan: Highlights From the 2024 San Antonio Breast Cancer SymposiumExperts presented results that may transform treatment and clinical practice strategies.
Latest:
Unrecognized Costs Associated With Clostridium Difficile Infection: What HCPs Often MissFrom an economic perspective, C. difficile has a staggering financial impact on the US health care system, as well on the patients infected.
Latest:
The Pharmacist's Role in Prior AuthorizationsThe prior authorization process often involves complex transactions and increases the burden not only on physicians and pharmacies, but can also impact patient access.
Latest:
All Pharmacies Are Not the Same: Community Pharmacy QualityPatients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Latest:
Advise Patients About OTC Options for Treating Motion SicknessMany cases of motion sickness can be managed safely with available OTC products.
Latest:
Leveraging Technology to Enhance Women’s Health and Access to CarePanelists discuss how digital health technologies revolutionize women’s health care through telehealth, mobile apps, and remote monitoring, expanding access, personalization, and proactive medical support.
Latest:
2023 Forecasts for Pharmacy Services, Medication Costs During the Rise of Personalized MedicineData from a recent survey reflect a resounding shift toward the role of pharmacies becoming sites for primary care.
Latest:
Empower Prospective Pharmacists through Children’s BooksThis short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.
Latest:
Pharmacy Department-Driven Initiative to Reduce Subcutaneous Daratumumab Observation TimeObservation time on subsequent injections of subcutaneous daratumumab may be safely removed from institutional policies to reduce chair time.
Latest:
Clinical Overview: A Novel Way of Treating SchizophreniaThe estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.
Latest:
Getting Medications Right: Five Questions Pharmacists, Physicians Should Ask PatientsWith a coordinated, interprofessional team supporting them, patients are empowered with information at the point-of-care to help manage medication therapy problems as they arise.
Latest:
Patient and Provider Safety is at the Core of Mass COVID-19 Immunization EffortAs new variants of the virus come to rise, it is crucial to continue to address the safety concerns with mass COVID-19 immunizations during the pandemic as well as provide solutions to reduce the exposure and spread of the virus.
Latest:
Asembia AXS25: How AI Will Reshape Prescription FulfillmentExperts emphasized the importance of addressing regulatory and payer-side challenges to fully leverage AI's potential in pharmacy settings.
Latest:
Clinical Overview: A Novel Way of Treating SchizophreniaThe estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.
Latest:
ELCC 2025: Amivantamab Plus Lazertinib Effective in EGFR-Mutated NSCLC Versus Standard of CareNicolas Girard, MD, explains the benefits observed in the MARIPOSA clinical trial among patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) treated with amivantamab plus lazertinib.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Latest:
Board Certification for Medical Science Liaisons: Implications for the Pharmaceutical IndustryMore than ever, confidence in objective, science-based data about therapeutics, such as the COVID-19 vaccine and other health care services, is a shared imperative across the pharmaceutical industry, health care communities, and the American public.
Latest:
Current Standards of Care in Platinum-Resistant Ovarian CancerFolate receptor α may be an important treatment target for ovarian tumors.
Latest:
Drug Shortages in Community Oncology: Ensuring Access to ChemotherapyPersistent chemotherapy drug shortages challenge oncology providers. American Oncology Network employs a drug shortage committee for organized shortage management that involves pharmacists and interdisciplinary stakeholders.
Latest:
New Curricular Framework Aims to Prepare, Inspire the Next Generation of Community Pharmacy LeadersThe framework includes 6 domains designed to immediately empower students in community pharmacies.
Latest:
The Pharmacy Model Is ChangingEmbracing artificial intelligence and other tools will be necessary to push the field forward.
Latest:
The Landscape of Drug Development and the Pharmaceutical Industry in Italy: Challenges, Trends, and the Role of GenericsGenerics play a crucial role in mitigating drug shortages by offering a real alternative for 80% of drugs that are becoming increasingly unavailable in Italy.
Latest:
More Scrutiny Means Strict Regulation and OpportunityPharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.
Latest:
Assessing Quadruplet vs Triplet Regimens in Up-front Multiple Myeloma TreatmentResearch indicates quadruplet regimens may be a viable option for this disease.
Latest:
Navigating the Shadows: Understanding the Psychology and Pharmacology of Treating Postpartum DepressionA new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.
Latest:
Understand the Effects of Topical Nasal Decongestants on Blood PressureBecause decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
